Unintentional Weight Loss¶
Chapter 50 | Unintentional Weight Loss
KEY CLINICAL POINTS¶
- Unintentional weight loss (UWL) is defined as >5% weight loss over 6–12 months without intentional dietary or lifestyle changes.
- UWL is frequently associated with serious underlying conditions, including cancer, chronic infections, metabolic disorders, and psychiatric illnesses.
- Age-related physiological changes (e.g., reduced taste/smell, slowed gastric emptying) and social factors (isolation, poverty) contribute to UWL in older adults.
- Diagnostic evaluation should prioritize cancer, infectious diseases, and metabolic causes, with multidisciplinary assessment for complex cases.
- Treatment depends on underlying cause, with nutritional support, pharmacologic intervention, and management of comorbidities as key components.
1. DEFINITION & OVERVIEW¶
Unintentional weight loss (UWL) refers to a significant reduction in body weight without deliberate dietary or lifestyle changes. Clinically important UWL is defined as >5% of body weight loss over 6–12 months. It is a critical red flag for underlying disease, particularly in older adults. UWL is associated with increased mortality and morbidity, including falls, fractures, and functional decline.
Table 50-1: Causes of Involuntary Weight Loss¶
| Category | Causes |
|---|---|
| Malignant Neoplasms | Cancer (gastrointestinal, hepatobiliary, hematologic, lung, breast, genitourinary, ovarian, prostate) |
| Chronic Inflammatory/Infectious Diseases | Tuberculosis, HIV, fungal infections, parasitic infections, subacute bacterial endocarditis |
| Metabolic Disorders | Hyperthyroidism, diabetes mellitus, pheochromocytoma, adrenal insufficiency |
| Psychiatric/Behavioral | Depression, anxiety, paranoia, bereavement, eating disorders |
| Medications | Sedatives, antibiotics, NSAIDs, SSRIs, metformin, levodopa, ACE inhibitors |
| Gastrointestinal Disorders | Dysphagia, malabsorption, peptic ulcer, IBD, pancreatitis, obstruction/constipation |
| Endocrine/Metabolic | Hyperthyroidism, diabetes mellitus, adrenal insufficiency |
| Neurologic | Stroke, Parkinson’s disease, dementia, spinal cord injury |
| Social/Environmental | Isolation, poverty, increased activity/exercise |
| Idiopathic | No identifiable cause in up to 25% of cases |
1.1 Physiological Changes with Aging¶
Total body weight peaks in the sixth decade and declines gradually after age 90. Lean body mass (fat-free mass) declines at 0.3 kg/year starting in the third decade, accelerating after age 60 in men and 65 in women. Telomere shortening and reduced IGF-I levels contribute to age-related muscle and fat loss. Decreased taste/smell, reduced chewing efficiency, and altered neuroendocrine function (e.g., leptin, CCK) impair appetite and nutrient intake.
2. EPIDEMIOLOGY¶
UWL is common in older adults ( ≥ 65 years), with up to 10% of community-dwelling elderly experiencing significant weight loss. Risk factors include advanced age, preexisting obesity, social isolation, poverty, and functional disabilities. In patients with cancer, UWL occurs in ~50% of cases, with >5% weight loss in ~33% and cachexia contributing to ~20% of cancer-related deaths. UWL is associated with increased mortality (1–2 years) and higher rates of falls, fractures, and pressure ulcers.
2.1 Demographics¶
Most prevalent in individuals ≥ 65 years. Preexisting obesity may mask weight loss, complicating documentation. Women may experience menopause-related sex steroid loss, contributing to body composition changes.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
UWL arises from four main categories: malignant disease, chronic infections/inflammation, metabolic disorders, and psychiatric factors. Pathophysiology includes increased metabolic demand (e.g., cancer cachexia, infections), reduced caloric intake (due to dysphagia, anorexia, or depression), and altered nutrient absorption (malabsorption, pancreatic insufficiency). Cytokine-mediated inflammation in depression and cancer disrupts appetite and metabolism.
3.1 Malignancy-Related Weight Loss¶
Cancer-associated cachexia involves tumor-secreted cytokines (TNF- α , IL-6) that increase resting energy expenditure and reduce muscle protein synthesis. Solid tumors (e.g., gastrointestinal, lung) most commonly cause UWL. Cachexia contributes to ~20% of cancer deaths via immobility and organ failure.
3.2 Infections & Inflammatory Diseases¶
Chronic infections (e.g., TB, HIV) and inflammatory conditions (e.g., IBD, sarcoidosis) increase metabolic demand and cause anorexia. Tuberculosis is a leading cause in resource-limited settings, with weight loss often preceding diagnostic findings.
4. CLINICAL FEATURES¶
Symptoms include progressive weight loss, fatigue, and reduced appetite. Physical findings may include cachexia, muscle wasting, and signs of underlying disease (e.g., jaundice for hepatobiliary cancer, neurological deficits for tumors). In older adults, UWL may present with functional decline rather than overt weight loss. Anorexia of aging (reduced hedonic food appreciation) is common but may mask serious pathology.
4.1 Red Flags for Serious Disease¶
Weight loss >10% in <6 months, associated fever, night sweats, or localized pain. Presence of new neurological deficits, unexplained anemia, or jaundice warrants urgent investigation.
5. DIFFERENTIAL DIAGNOSIS¶
Differential diagnosis includes: 1) Malignancies (gastrointestinal, lung, hematologic), 2) Chronic infections (TB, HIV, fungal), 3) Metabolic disorders (hyperthyroidism, diabetes), 4) Psychiatric conditions (depression, dementia), 5) Gastrointestinal diseases (IBD, celiac disease), 6) Medication side effects (NSAIDs, antipsychotics), 7) Endocrine disorders (adrenal insufficiency, pheochromocytoma).
5.1 Age-Related Considerations¶
In older adults, UWL may be due to frailty, malnutrition, or functional disability rather than specific disease. However, cancer, IBD, and diabetes remain leading causes.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnostic workup includes: 1) History of weight changes, dietary habits, and comorbidities, 2) Physical examination for signs of infection, malignancy, or neurological disease, 3) Laboratory tests (CBC, metabolic panel, thyroid function, inflammatory markers), 4) Imaging (CT, endoscopy), 5) Tumor markers (CEA, CA125, PSA), 6) Endoscopic evaluation for GI malignancies. UWL >10% warrants urgent investigation.
6.1 Diagnostic Algorithms¶
- Confirm weight loss >5% over 6–12 months. 2. Evaluate for cancer (history of smoking, localized symptoms, abnormal labs). 3. Test for infections (TB, HIV, fungal). 4. Assess metabolic causes (thyroid, diabetes). 5. Screen for psychiatric disorders. 6. Consider malabsorption or dysphagia if gastrointestinal symptoms are present.
7. MANAGEMENT & TREATMENT¶
Management is tailored to underlying cause: 1) Nutritional support (high-protein diets, enteral nutrition), 2) Treatment of malignancy (chemotherapy, palliative care), 3) Antimicrobial therapy for infections, 4) Hormone replacement for endocrine disorders, 5) Antidepressants for psychiatric comorbidities. For elderly patients, address functional disabilities and social determinants of health.
7.1 Palliative Care Considerations¶
In advanced cancer, focus on symptom management and quality of life. Nutritional support may include parenteral nutrition if oral intake is inadequate. Address cachexia with appetite stimulants (megestrol, dronabinol) and metabolic modulation.
8. PROGNOSIS & COMPLICATIONS¶
UWL is associated with increased mortality (1–2 years) and higher risk of complications: falls, fractures, pressure ulcers, and functional decline. In cancer patients, cachexia contributes to ~20% of deaths. Early intervention improves outcomes, particularly in treatable causes (e.g., infections, malabsorption).
8.1 Long-Term Outcomes¶
Weight restoration is possible with successful treatment of underlying disease. Persistent UWL despite investigation may indicate idiopathic cachexia or advanced malignancy, requiring palliative care.
9. SPECIAL CONSIDERATIONS¶
In older adults, UWL may be due to frailty or social factors rather than specific disease. Address isolation, poverty, and functional disabilities. In psychiatric cases, treat depression with SSRIs or SNRIs. For malabsorption, investigate celiac disease or pancreatic insufficiency. Monitor for drug-induced weight loss (e.g., antipsychotics, corticosteroids).
9.1 Geriatric Management¶
Use validated tools (e.g., MNA-SF) to assess nutritional risk. Multidisciplinary care involving dietitians, geriatricians, and social workers is essential for complex cases.
10. KEY POINTS & CLINICAL PEARLS¶
- UWL >5% over 6–12 months is a red flag for serious disease. 2. Cancer is the most common cause in adults, while frailty and social factors are more prevalent in older adults. 3. Investigate malignancy, infections, and metabolic disorders in all patients. 4. Nutritional support and treatment of underlying causes are critical. 5. In idiopathic cases, monitor for progressive weight loss and consider advanced imaging or biopsy.